In this episode of the Life Science Success Podcast my guest is Dean Erhardt, President and CEO at D2 Solutions. He brings more than 20 years of experience across pharmaceuticals and consumer products, with expertise in support program development, distribution, and specialty product management, and has worked with over 100 pharmaceutical, biotech, and medical device manufacturers as well as many small and midsized organizations on commercial operations, strategy, and national accounts.

00:00 Intro

00:34 Dean's career: HMO, Cardinal Health, Express Scripts

03:00 Founding D2 Solutions in 2008

04:00 Pricing strategy and middlemen taking 50–70% of revenue

08:00 What separates successful commercialization from failure

10:00 D2's three pillars: distribution, reimbursement, patient services

15:00 Pharmaceutical support programs for specialty medications

16:00 D2's digital patient engagement platform in action

21:00 Resource challenges for small and mid-sized pharma

22:00 Retail deserts and the rise of direct-to-consumer models

24:00 National accounts strategy and long-term payer relationships

26:00 When to engage D2 and cleaning up commercialization missteps

28:00 The prior authorization crisis

31:00 Leadership advice: one vision, said a million times

32:00 AI, remote surgery, and the future of care

34:00 Looming shortage of 3.9 million healthcare workers

36:00 Concerns: aging population, lost patients, NIH funding

37:00 Technology accelerating drug approvals

38:00 Outro

Dean Erhardt: Pharma Strategy, Distribution & Commercial Growth